- Investing Ideas
- /
- U.S. Large Cap High Growth Potential
U.S. Large Cap High Growth Potential
Results
235
8 new
Large Cap Companies that analysts expect to have high earnings, revenue or cash flow growth in the next 3 years.
235 companies
| Company | Last Price | 7D Return | 1Y Return | Market Cap | Analysts Target | Valuation | Growth | Div Yield | Industry | ||
|---|---|---|---|---|---|---|---|---|---|---|---|
EQT New | US$50.08 | -6.3% | 36.3% | US$30.0b | US$53.69 | PE129.8x | E33.1% | 1.3% | Energy | ||
AFRM | US$66.51 | -17.6% | 78.1% | US$21.8b | US$73.65 | PS7.6x | E55.8% | n/a | Diversified Financials | ||
GEV | US$315.91 | -14.1% | n/a | US$90.5b | US$417.18 | PE56.2x | E25.1% | 0.3% | Capital Goods | ||
FICO | US$1,732.20 | -3.7% | 34.5% | US$41.5b | US$2,031.00 | PE77.7x | E18.5% | 0% | Software | ||
CSGP | US$77.49 | 4.6% | -7.7% | US$31.5b | US$85.93 | PE229.1x | E34.9% | n/a | Real Estate Management and Development | ||
ORCL | US$169.96 | -2.4% | 53.2% | US$469.4b | US$194.64 | PE40.9x | E15.7% | 0.9% | Software | ||
GILD | US$111.03 | 6.7% | 52.2% | US$137.0b | US$107.59 | PE288.3x | E23.6% | 2.8% | Pharmaceuticals & Biotech | ||
OC New | US$162.89 | -9.2% | 10.6% | US$14.2b | US$209.72 | PE21.6x | E29.0% | 1.7% | Capital Goods | ||
INTU | US$567.24 | -3.4% | -14.6% | US$158.3b | US$719.24 | PE54.4x | E17.2% | 0.7% | Software | ||
IP | US$55.30 | -1.5% | 63.6% | US$29.2b | US$56.95 | PE52.2x | E22.7% | 3.3% | Materials | ||
PANW | US$190.39 | -4.8% | 25.8% | US$126.5b | US$212.92 | PE100.5x | E17.5% | n/a | Software | ||
EQH | US$53.30 | -3.7% | 54.7% | US$15.9b | US$59.90 | PE13.5x | E17.9% | 1.8% | Diversified Financials | ||
NTRA | US$158.37 | -8.7% | 113.5% | US$21.4b | US$179.67 | PS13.6x | E70.4% | n/a | Pharmaceuticals & Biotech | ||
FIS | US$69.37 | 0.6% | 3.0% | US$37.0b | US$85.29 | PE46.7x | E24.5% | 2.3% | Diversified Financials | ||
HLI | US$170.68 | -4.3% | 30.3% | US$12.0b | US$191.71 | PE33.4x | E19.8% | 1.3% | Diversified Financials | ||
TSLA | US$330.53 | -7.1% | 65.8% | US$1.1t | US$345.56 | PE149.1x | E22.3% | n/a | Automobiles | ||
APH | US$67.13 | -2.5% | 24.2% | US$81.8b | US$84.08 | PE33.5x | E14.7% | 1.0% | Tech | ||
CTVA | US$62.61 | -2.1% | 14.2% | US$43.0b | US$69.00 | PE50.4x | E24.5% | 1.1% | Materials | ||
MEDP | US$344.34 | 1.2% | -14.6% | US$10.4b | US$344.83 | PE25.9x | E9.6% | n/a | Pharmaceuticals & Biotech | ||
BAX | US$35.08 | 13.8% | -16.5% | US$17.3b | US$39.78 | PS1.7x | E50.7% | 1.9% | Healthcare | ||
GEN | US$27.35 | -1.3% | 27.2% | US$16.7b | US$31.37 | PE26.3x | E14.6% | 1.8% | Software | ||
VTRS | US$11.39 | 5.5% | -15.2% | US$13.4b | US$13.20 | PS0.9x | E52.4% | 4.2% | Pharmaceuticals & Biotech | ||
PTC | US$162.58 | -5.0% | -10.5% | US$19.5b | US$214.12 | PE49.9x | E15.8% | n/a | Software | ||
AZPN | US$263.80 | -0.4% | 41.4% | US$16.7b | US$265.65 | PE2724x | E42.1% | n/a | Software |